Evaluation of the Single-Dose Toxicity of Capsaicin Containing Pharmacopuncture in RatsEvaluation of the Single-Dose Toxicity of Capsaicin Containing Pharmacopuncture in Rats
- Other Titles
- Evaluation of the Single-Dose Toxicity of Capsaicin Containing Pharmacopuncture in Rats
- Authors
- 황지혜; 구자승; Chul Jung
- Issue Date
- Aug-2020
- Publisher
- 대한침구의학회
- Keywords
- acupuncture; capsaicin; pharmacopuncture; safety; toxicity
- Citation
- Journal of Acupuncture Research, v.37, no.3, pp.167 - 172
- Journal Title
- Journal of Acupuncture Research
- Volume
- 37
- Number
- 3
- Start Page
- 167
- End Page
- 172
- URI
- https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/78095
- DOI
- 10.13045/jar.2020.00185
- ISSN
- 2586-288X
- Abstract
- Background: This study aimed to assess the toxicity of capsaicin (CP) pharmacopunture in an animal model.
Methods: The toxicity of a single-muscular dose of CP (45.45 mg/mL) was evaluated in 6-week-old male and female Sprague-Dawley rats. A total of 20 rats were assigned to 2 groups which were sex and weight matched.
All rats acclimatized for 1 week before receiving 1.0 mL of CP (45.45 mg/mL) or normal saline solution (control) intramuscularly. The general condition and mortality of the animals were observed. The rats were sacrificed 2 weeks after CP was administered and histopathology was performed.
Results: No abnormal symptoms or deaths were observed, and there was no difference in body weights between the CP and control groups throughout the study. No significant differences in histopathology were observed between the groups.
Conclusion: No toxicological changes related to the administration of CP were observed. This study indicated that the safe dose of CP in Sprague-Dawley rats was 1.0 mL of CP (45.45 mg/mL) or less. Further studies are needed to confirm the safety of CP in the human body.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 한의과대학 > 한의학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.